http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8758287-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61addec9d20545bfb8b10a9640f057b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66f5691cc8767198f07bd9cd2dd356e3 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3687 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3689 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-00 |
filingDate | 2009-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95dba6b41c6e85723c6f7fea9d9684f3 |
publicationDate | 2014-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-8758287-B2 |
titleOfInvention | Utilization of stents for the treatment of blood borne carcinomas |
abstract | A filter and a method treat blood borne carcinomas by inducing apoptosis in carcinoma cells. The filter includes comprises a stent having an interior wall defining a channel containing a packing material and at least one antineoplastic agent. The method includes placing a patient's blood in apposition of the antineoplastic agent by pumping the blood through the stent. The blood remains in apposition to the antineoplastic agent for a sufficient time period to induce an apoptotic cascade. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11186629-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014241944-A1 |
priorityDate | 2008-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 153.